Product mentioned on podcasts
Retrotide
by Eli Lilly
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links.
Who mentioned it
“Dr. Tatem revealed that Retrotide, Lilly's forthcoming triple-receptor GLP-1 drug targeting GLP-1, GIP, and glucagon simultaneously, has already been self-administered by bodybuilders and biohackers for two years via research-use-only markets”
Mentioned on: The Diary of a CEO